“…The ASA and RT-QuIC are generally analogous to sPMCA, but employ recombinant PrP C instead of brain homogenate as substrate for disease-specific, in vitro, amyloid formation (Atarashi et al, 2007(Atarashi et al, , 2011aColby et al, 2007). RT-QuIC offers the advantage of real-time assessment of amyloid fibril generation and has been successfully applied to many seed sources, some of which are available for antemortem sampling (Atarashi et al, 2011a, b;Elder et al, 2013;Haley et al, 2013;Henderson et al, 2013;McGuire et al, 2012;Orrú et al, 2011Orrú et al, , 2014Peden et al, 2011;Sano et al, 2013;Wilham et al, 2010).…”